Boris Blechacz

5.1k total citations · 4 hit papers
36 papers, 3.2k citations indexed

About

Boris Blechacz is a scholar working on Surgery, Epidemiology and Molecular Biology. According to data from OpenAlex, Boris Blechacz has authored 36 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Boris Blechacz's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). Boris Blechacz is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). Boris Blechacz collaborates with scholars based in United States, Germany and Belgium. Boris Blechacz's co-authors include Gregory J. Gores, Tania Roskams, Mina Komuta, Stephen J. Russell, Yezaz A. Ghouri, Idrees Mian, Elizabeth A. Conner, Jesper B. Andersen, Bart Spee and Snorri S. Thorgeirsson and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Boris Blechacz

35 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholangiocarcinoma

2008 541 citations Boris Blechacz, Gregory J. Gores Hepatology profile →
Clinical diagnosis and staging of cholangiocarcinoma

2011 520 citations Boris Blechacz, Mina Komuta et al. Nature Reviews Gastroenterology & Hepatology profile →
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors

2011 384 citations Boris Blechacz, Mina Komuta et al. profile →
Cholangiocarcinoma: Current Knowledge and New Developments

2016 331 citations Boris Blechacz profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boris Blechacz United States	20	1.9k	1.3k	827	820	591	36	3.2k
Murli Krishna United States	27	1.2k 0.7×	873 0.7×	307 0.4×	674 0.8×	155 0.3×	99	2.4k
Takeshi Todoroki Japan	28	1.1k 0.6×	869 0.7×	484 0.6×	581 0.7×	200 0.3×	88	2.2k
Victoria Marcus Canada	26	649 0.3×	824 0.7×	521 0.6×	307 0.4×	411 0.7×	72	2.2k
Joanna H. Tong Hong Kong	37	550 0.3×	1.3k 1.0×	2.3k 2.8×	1.0k 1.2×	1.3k 2.2×	62	4.4k
Takatoshi Ishiko Japan	29	807 0.4×	1.3k 1.1×	1.4k 1.7×	342 0.4×	448 0.8×	141	3.4k
Tsung‐Teh Wu United States	30	1.5k 0.8×	685 0.5×	404 0.5×	1.2k 1.5×	184 0.3×	88	3.3k
Takehide Asano Japan	27	1.3k 0.7×	1.2k 0.9×	401 0.5×	748 0.9×	139 0.2×	116	2.5k
Christopher Siegel United States	21	698 0.4×	751 0.6×	535 0.6×	259 0.3×	530 0.9×	51	2.4k
Yutaka Suehiro Japan	36	487 0.3×	1.4k 1.1×	1.6k 2.0×	495 0.6×	771 1.3×	144	3.5k
Hye Seung Han South Korea	27	766 0.4×	683 0.5×	596 0.7×	734 0.9×	258 0.4×	107	2.3k

Countries citing papers authored by Boris Blechacz

Since Specialization

Citations

This map shows the geographic impact of Boris Blechacz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Blechacz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Blechacz more than expected).

Fields of papers citing papers by Boris Blechacz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Blechacz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Blechacz. The network helps show where Boris Blechacz may publish in the future.

Co-authorship network of co-authors of Boris Blechacz

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Blechacz. A scholar is included among the top collaborators of Boris Blechacz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Blechacz. Boris Blechacz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Daver, Naval, Kenneth L. McClain, Carl E. Allen, et al.. (2017). A consensus review on malignancy‐associated hemophagocytic lymphohistiocytosis in adults. Cancer. 123(17). 3229–3240. 143 indexed citations

Hust, Michael, Boris Blechacz, Diana L. Bonilla, Naval Daver, & Cristhiam M. Rojas‐Hernandez. (2017). Adult cancer-related hemophagocytic lymphohistiocytosis – a challenging diagnosis: a case report. Journal of Medical Case Reports. 11(1). 172–172. 1 indexed citations

Rojas, Andrés, Pingyu Zhang, Ying Wang, et al.. (2016). A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer. Neoplasia. 18(6). 371–386. 27 indexed citations

Torres, Harrys A., Parag Mahale, Minas P. Economides, et al.. (2016). Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center. Journal of the National Comprehensive Cancer Network. 14(9). 1185–1188. 2 indexed citations

Zhu, Haifeng, Zuzana Berkova, Rohit Mathur, et al.. (2015). HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer. Molecular Cancer Research. 13(5). 809–818. 40 indexed citations

Blechacz, Boris, Yezaz A. Ghouri, & Idrees Mian. (2015). Cancer review: Cholangiocarcinoma. Journal of Carcinogenesis. 14(1). 1–1. 118 indexed citations

Thabut, Dominique, Chittaranjan Routray, Gwen Lomberk, et al.. (2011). Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology. 54(2). 573–585. 88 indexed citations

Blechacz, Boris, Mina Komuta, Tania Roskams, & Gregory J. Gores. (2011). Clinical diagnosis and staging of cholangiocarcinoma. Nature Reviews Gastroenterology & Hepatology. 8(9). 512–522. 520 indexed citations breakdown →

Smoot, Rory L., Boris Blechacz, Nathan W. Werneburg, et al.. (2010). A Bax-Mediated Mechanism for Obatoclax-Induced Apoptosis of Cholangiocarcinoma Cells. Cancer Research. 70(5). 1960–1969. 43 indexed citations

10.

Fingas, Christian D., Boris Blechacz, Rory L. Smoot, et al.. (2010). A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)‐induced invasion and metastasis of cholangiocarcinoma cells†. Hepatology. 52(2). 550–561. 50 indexed citations

11.

Blechacz, Boris & Gregory J. Gores. (2010). Positron Emission Tomography Scan for a Hepatic Mass. Hepatology. 52(6). 2186–2191. 18 indexed citations

12.

Blechacz, Boris, Rory L. Smoot, Steven F. Bronk, et al.. (2009). Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2†. Hepatology. 50(6). 1861–1870. 103 indexed citations

13.

Briel, Matthias, Ignacio Ferreira‐González, John J. You, et al.. (2008). Abstract 1688: Impact of Change in High-Density Lipoprotein Cholesterol on Cardiovascular Disease Morbidity and Mortality: Systematic Review and Meta-Regression Analysis. Circulation. 118. 2 indexed citations

14.

Blechacz, Boris & Stephen J. Russell. (2008). Measles Virus as An Oncolytic Vector Platform. Current Gene Therapy. 8(3). 162–175. 33 indexed citations

15.

Blechacz, Boris & Gregory J. Gores. (2008). Cholangiocarcinoma. Clinics in Liver Disease. 12(1). 131–150. 153 indexed citations

16.

Blechacz, Boris & Ognjen Gajic. (2008). Severe Kyphosis. New England Journal of Medicine. 358(24). e28–e28. 9 indexed citations

17.

Blechacz, Boris, Patrick L. Splinter, Suzanne Greiner, et al.. (2006). Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology. 44(6). 1465–1477. 98 indexed citations

18.

Blechacz, Boris & Stephen J. Russell. (2004). Parvovirus vectors: use and optimisation in cancer gene therapy. Expert Reviews in Molecular Medicine. 6(16). 1–24. 11 indexed citations

19.

Blechacz, Boris & Wolfgang Stremmel. (2003). NASH. Zeitschrift für Gastroenterologie. 41(1). 77–90. 3 indexed citations

20.

Moehler, Markus, Boris Blechacz, Wolfgang Stremmel, et al.. (2001). Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors. Cancer Gene Therapy. 8(3). 158–167. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact